NUZ 0.00% 20.5¢ neurizon therapeutics limited

Ann: Phase IIb Canine Trial Identifies Therapeutic Window for MPL, page-70

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 8,959 Posts.
    lightbulb Created with Sketch. 1740
    Where is the proof of this so called material progress.
    The facts are the facts, canine testing with new tablet started nearly 3 years ago and really it appears it will go on for another 6 months.
    How many times have we even told they are in discussions in relation to MPL usage but months go past and nothing.
    What is happening to data form ONJ.
    MPL has been proven safe in humans, we have covid killing thousands and yet after 9 months, 3 positve results not counting Leiden and what has been achieved in those nine months.
    Where is the progress oh yes from one test to another and another
 
watchlist Created with Sketch. Add NUZ (ASX) to my watchlist
(20min delay)
Last
20.5¢
Change
0.000(0.00%)
Mkt cap ! $99.76M
Open High Low Value Volume
0.0¢ 0.0¢ 0.0¢ $0 0

Buyers (Bids)

No. Vol. Price($)
2 4776 21.0¢
 

Sellers (Offers)

Price($) Vol. No.
20.5¢ 4775 1
View Market Depth
Last trade - 08.03am 29/10/2024 (20 minute delay) ?
NUZ (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.